Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Recombinant turkey herpesvirus vaccine strain coexpressing H5 subtype avian influenza HA protein and infectious bursal VP2 protein

A technology of turkey herpes virus and avian influenza virus, which is applied in the direction of double-stranded RNA virus, double-stranded DNA virus, antisense single-stranded RNA virus, etc., and can solve problems such as interference, spreading virus, and many side effects

Inactive Publication Date: 2018-09-18
HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although traditional vaccines can provide effective protection to poultry, they also have many shortcomings. For example, the disadvantages of inactivated vaccines for avian influenza are poor immunogenicity, many side effects, and large dosages. [2] The disadvantages of infectious bursal disease vaccines mainly include: attenuated live vaccines are susceptible to interference from maternal antibodies; moderately virulent live vaccines can damage the bursa and have the risk of spreading the virus; inactivated vaccines cannot Induce the body to produce strong immunity, unable to resist the attack of strong virus strains, etc. [3]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant turkey herpesvirus vaccine strain coexpressing H5 subtype avian influenza HA protein and infectious bursal VP2 protein
  • Recombinant turkey herpesvirus vaccine strain coexpressing H5 subtype avian influenza HA protein and infectious bursal VP2 protein
  • Recombinant turkey herpesvirus vaccine strain coexpressing H5 subtype avian influenza HA protein and infectious bursal VP2 protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] The present invention will be further described below with reference to specific examples, but those skilled in the art should understand that the present invention is not limited to these specific examples.

[0031] Reagents and the like used in the following embodiments are commercially available products unless otherwise specified.

[0032] 1 material

[0033] 1.1 Virus strains, plasmids and cell lines

[0034] Turkey herpes virus (HVT) strain FC126 was purchased from the China Veterinary Drug Control Institute; avian influenza virus strain A / Chicken / Guizhou / 4 / 2013 (H5N1) (CK / GZ / 4 / 13 for short) was purchased from the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences The National Avian Influenza Reference Laboratory was isolated and preserved. The infectious bursal virus IBDV HLJ-0504 strain was provided by the Innovation Team of Poultry Immunosuppressive Diseases, Harbin Veterinary Research Institute, Chinese Academy of Agricultura...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a recombinant turkey herpesvirus vaccine strain coexpressing an H5 subtype avian influenza HA protein and an infectious bursal VP2 protein, and an application thereof. The preservation number of the recombinant turkey herpesvirus vaccine strain coexpressing H5 subtype avian influenza HA gene and infectious bursal VP2 gene is CCTCC NO:V201738. The invention also provides atriple vaccine for preventing avian influenza virus, infectious bursal disease virus and Marek virus. The triple vaccine comprises an effective amount of the recombinant turkey herpesvirus vaccine strain coexpressing the H5 subtype avian influenza HA gene and the infectious bursal VP2 gene.

Description

[0001] This application claims the priority of the invention patent application 201711428339.1 submitted on December 25, 2017. technical field [0002] The invention relates to a recombinant virus vaccine, in particular to a recombinant turkey herpes virus vaccine strain co-expressing H5 subtype avian influenza HA protein and infectious bursa VP2 protein and application thereof. Background technique [0003] Avian influenza virus (Avain influenza virus, AIV) and infectious bursa virus (Infectious bursa disease virus, IBDV) are two important viral infectious diseases that endanger the development of my country's poultry industry, causing serious economic losses to the poultry industry. [1] . Currently, the main means of controlling these two infectious diseases is immunization with vaccines. Although traditional vaccines can provide effective protection to poultry, they also have many shortcomings. For example, the disadvantages of inactivated avian influenza vaccines are po...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/12A61P31/14A61K39/145A61P31/16A61K39/245A61P31/22C12N15/85C12N7/01C12R1/93
CPCA61K39/12A61P31/14A61P31/16A61P31/22C12N7/00C12N15/85C07K14/005C12N2720/10022C12N2720/10034C12N2710/16334C12N2710/16321C12N2760/16134C12N2760/16122A61K2039/70A61K2300/00
Inventor 陈化兰陈普成姜永萍柳金雄邓国华曾显营高立
Owner HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com